- Home
- RVTY vs BMRN Comparison
RVTY vs BMRN Comparison
Compare RVTY & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVTY
- BMRN
- Stock Information
- Founded
- RVTY 1937
- BMRN 1996
- Country
- RVTY United States
- BMRN United States
- Employees
- RVTY N/A
- BMRN 3040
- Industry
- RVTY Biotechnology: Laboratory Analytical Instruments
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- RVTY Industrials
- BMRN Health Care
- Exchange
- RVTY Nasdaq
- BMRN Nasdaq
- Market Cap
- RVTY 9.9B
- BMRN 9.9B
- IPO Year
- RVTY N/A
- BMRN 1999
- Fundamental
- Price
- RVTY $90.78
- BMRN $51.46
- Analyst Decision
- RVTY Buy
- BMRN Buy
- Analyst Count
- RVTY 15
- BMRN 19
- Target Price
- RVTY $117.43
- BMRN $90.26
- AVG Volume (30 Days)
- RVTY 1.4M
- BMRN 2.9M
- Earning Date
- RVTY 10-27-2025
- BMRN 10-27-2025
- Dividend Yield
- RVTY 0.31%
- BMRN N/A
- EPS Growth
- RVTY N/A
- BMRN 59.53
- EPS
- RVTY 1.99
- BMRN 2.68
- Revenue
- RVTY $2,813,367,000.00
- BMRN $3,094,001,000.00
- Revenue This Year
- RVTY $5.37
- BMRN $13.32
- Revenue Next Year
- RVTY $3.07
- BMRN $7.51
- P/E Ratio
- RVTY $46.57
- BMRN $19.20
- Revenue Growth
- RVTY 3.37
- BMRN 12.39
- 52 Week Low
- RVTY $81.36
- BMRN $50.76
- 52 Week High
- RVTY $128.29
- BMRN $73.51
- Technical
- Relative Strength Index (RSI)
- RVTY 45.25
- BMRN 40.53
- Support Level
- RVTY $90.34
- BMRN $51.80
- Resistance Level
- RVTY $93.32
- BMRN $53.49
- Average True Range (ATR)
- RVTY 3.11
- BMRN 1.84
- MACD
- RVTY -0.82
- BMRN -0.08
- Stochastic Oscillator
- RVTY 16.97
- BMRN 12.58
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.